Abstract
Establishing codon usage biases are crucial for understanding the etiology of central nervous system neurodegenerative diseases (CNSNDD) especially Alzheimers disease (AD) as well as genetic factors. G and C ending codons are strongly biased in the coding sequences of these proteins as a result of genomic GC composition constraints. On the other hand, codons that identified as translationally optimal in the major trend all end in C or G, suggesting translational selection should also be taken into consideration additional to compositional constraints. Furthermore, this investigation reveals that three common codons, CGC (Arg), AGC (Ser), and GGC (Gly), are also critical in affecting codon usage bias. They not only can offer an insight into the codon usage bias of AD and its mechanism, but also may help in the possible cures for these diseases.
Keywords: Codon usage, compositional constraints, translational selection, correspondence analysis
Protein & Peptide Letters
Title: Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Volume: 17 Issue: 5
Author(s): Jie Yang, Tong-Yang Zhu, Zheng-Xin Jiang, Cheng Chen, Yue-Lan Wang, Song Zhang, Xiong-Fei Jiang, Ting-Ting Wang, Lin Wang, Wen-Hao Xia, Lei Li, Ji-Jun Chen, Jia-Yue Wang, Wei-Wei Wang and Wei-Juan Zheng
Affiliation:
Keywords: Codon usage, compositional constraints, translational selection, correspondence analysis
Abstract: Establishing codon usage biases are crucial for understanding the etiology of central nervous system neurodegenerative diseases (CNSNDD) especially Alzheimers disease (AD) as well as genetic factors. G and C ending codons are strongly biased in the coding sequences of these proteins as a result of genomic GC composition constraints. On the other hand, codons that identified as translationally optimal in the major trend all end in C or G, suggesting translational selection should also be taken into consideration additional to compositional constraints. Furthermore, this investigation reveals that three common codons, CGC (Arg), AGC (Ser), and GGC (Gly), are also critical in affecting codon usage bias. They not only can offer an insight into the codon usage bias of AD and its mechanism, but also may help in the possible cures for these diseases.
Export Options
About this article
Cite this article as:
Yang Jie, Zhu Tong-Yang, Jiang Zheng-Xin, Chen Cheng, Wang Yue-Lan, Zhang Song, Jiang Xiong-Fei, Wang Ting-Ting, Wang Lin, Xia Wen-Hao, Li Lei, Chen Ji-Jun, Wang Jia-Yue, Wang Wei-Wei and Zheng Wei-Juan, Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases, Protein & Peptide Letters 2010; 17 (5) . https://dx.doi.org/10.2174/092986610791112666
DOI https://dx.doi.org/10.2174/092986610791112666 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives
Letters in Drug Design & Discovery Feature Extraction, Risky Classifications and Fault Diagnosis on Rolling Bearings of EEG Signals Denoised using Stationary Wavelet Transform of Patient Monitoring and IoT
Current Medical Imaging The Role of Peripheral Benzodiazepine Receptors (PBRs) in CNS Pathophysiology
Current Medicinal Chemistry Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior
Current Genomics Targeting BLyS in Systemic Lupus Erythematosus
Recent Patents on Inflammation & Allergy Drug Discovery Hematologic Abnormalities in the Antiphospholipid Syndrome
Current Rheumatology Reviews The Endocannabinoid System May Modulate Sleep Disorders in Aging
Current Neuropharmacology Mathematical Modelling and Feature Extraction for Probing Crucial Changes Associated with Alzheimers Disease
Current Medical Imaging Herbal Compounds with Special Reference to Gastrodin as Potential Therapeutic Agents for Microglia Mediated Neuroinflammation
Current Medicinal Chemistry Characterization of a New Positive Allosteric Modulator of AMPA Receptors - PAM-43: Specific Binding of the Ligand and its Ability to Potentiate AMPAR Currents
Current Molecular Pharmacology Role of ABC Transporters in the Chemoresistance of Human Gliomas
Current Cancer Drug Targets Genes, Blame and Loss of Control: is there a Place in Criminal Law for a ‘Genetic Defense’?
Recent Advances in DNA & Gene Sequences (Discontinued) Clinical Trials for Neuroprotection in ALS
CNS & Neurological Disorders - Drug Targets Non-adenosine Nucleoside Inosine, Guanosine and Uridine as Promising Antiepileptic Drugs: a Summary of Current Literature
Mini-Reviews in Medicinal Chemistry Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Current Drug Abuse Reviews Nutraceuticals for Protection and Healing of Gastrointestinal Mucosa
Current Medicinal Chemistry Synthetic Cannabinoids as Drugs of Abuse
Current Drug Abuse Reviews Endocrine Abnormalities Induced by Antiepileptic Drugs
Current Pediatric Reviews Nonnucleoside Inhibitors of Adenosine Kinase
Current Pharmaceutical Design